The forkhead transcription factor FOXP1 represses human plasma cell differentiation

Blood

Volumn 126, Issue 18, 2015, Pages 2098-2109

  Van Keimpema, Martine ^a   Grüneberg, Leonie J ^a   Mokry, Michal ^b   Van Boxtel, Ruben ^b   Van Zelm, Menno C ^c   Coffer, Paul ^b   Pals, Steven T ^a   Spaargaren, Marcel ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD27 ANTIGEN; CD40 LIGAND; FORKHEAD TRANSCRIPTION FACTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 2; INTERLEUKIN 21; MESSENGER RNA; PROTEIN BCL 6; TRANSCRIPTION FACTOR FOXP1; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; FOXP1 PROTEIN, HUMAN; REPRESSOR PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOGLOBULIN PRODUCTION; MEMORY CELL; MICROARRAY ANALYSIS; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL CULTURE; CELL LINE; CYTOLOGY; GENETICS; METABOLISM; TRANSCRIPTION INITIATION; UPREGULATION;

B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PLASMA CELLS; REPRESSOR PROTEINS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84945538610     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-02-626176     Document Type: Article

References (56)

1. McHeyzer-Williams LJ, McHeyzer-Williams MG. Antigen-specific memory B cell development. Annu Rev Immunol. 2005; 23 (1): 487-513.
2. Yoshida T, Mei H, Dörner T, et al. Memory B and memory plasma cells. Immunol Rev. 2010; 237 (1): 117-139.
3. Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat Rev Immunol. 2005; 5 (3): 230-242.
4. Nutt SL, Taubenheim N, Hasbold J, Corcoran LM, Hodgkin PD. The genetic network controlling plasma cell differentiation. Semin Immunol. 2011; 23 (5): 341-349.
5. Klein U, Casola S, Cattoretti G, et al. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol. 2006; 7 (7): 773-782.
6. Sciammas R, Shaffer AL, Schatz JH, Zhao H, Staudt LM, Singh H. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity. 2006; 25 (2): 225-236.
7. Kwon H, Thierry-Mieg D, Thierry-Mieg J, et al. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity. 2009; 31 (6): 941-952.
8. Ochiai K, Maienschein-Cline M, Simonetti G, et al. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity. 2013; 38 (5): 918-929.
9. Shaffer AL, Shapiro-Shelef M, Iwakoshi NN, et al. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity. 2004; 21 (1): 81-93.
10. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity. 2000; 13 (2): 199-212.
11. Lin KI, Angelin-Duclos C, Kuo TC, Calame K. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol Cell Biol. 2002; 22 (13): 4771-4780.
12. Nera KP, Kohonen P, Narvi E, et al. Loss of Pax5 promotes plasma cell differentiation. Immunity. 2006; 24 (3): 283-293.
13. Tunyaplin C, Shaffer AL, Angelin-Duclos CD, Yu X, Staudt LM, Calame KL. Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol. 2004; 173 (2): 1158-1165.
14. Lenz G, Wright GW, Emre NC, et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA. 2008; 105 (36): 13520-13525.
15. Iqbal J, Greiner TC, Patel K, et al; Leukemia/ Lymphoma Molecular Profiling Project. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia. 2007; 21 (11): 2332-2343.
16. Mandelbaum J, Bhagat G, Tang H, et al. BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer Cell. 2010; 18 (6): 568-579.
17. Iida S, Rao PH, Nallasivam P, et al. The t (9; 14) (p13; q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood. 1996; 88 (11): 4110-4117.
18. Rui L, Schmitz R, Ceribelli M, Staudt LM. Malignant pirates of the immune system. Nat Immunol. 2011; 12 (10): 933-940.
19. Lenz G, Staudt LM. Aggressive lymphomas. N Engl J Med. 2010; 362 (15): 1417-1429.
20. Hu H, Wang B, Borde M, et al. Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol. 2006; 7 (8): 819-826.
21. Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A. T (3; 14) (p14.1; q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia. 2005; 19 (4): 652-658.
22. Fenton JAL, Schuuring E, Barrans SL, et al. t (3; 14) (p14; q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma. Genes Chromosomes Cancer. 2006; 45 (2): 164-168.
23. Banham AH, Connors JM, Brown PJ, et al. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Clin Cancer Res. 2005; 11 (3): 1065-1072.
24. Sagaert X, de Paepe P, Libbrecht L, et al. Forkhead box protein P1 expression in mucosaassociated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma. J Clin Oncol. 2006; 24 (16): 2490-2497.
25. van Keimpema M, Grüneberg LJ, Mokry M, et al. FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-kB to promote survival of human B cells. Blood. 2014; 124 (23): 3431-3440.
26. Sagardoy A, Martinez-Ferrandis JI, Roa S, et al. Downregulation of FOXP1 is required during germinal center B-cell function. Blood. 2013; 121 (21): 4311-4320.
27. Scheeren FA, Naspetti M, Diehl S, et al. STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat Immunol. 2005; 6 (3): 303-313.
28. Schmidlin H, Diehl SA, Nagasawa M, et al. Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression. Blood. 2008; 112 (5): 1804-1812.
29. Ding BB, Bi E, Chen H, Yu JJ, Ye BH. IL-21 and CD40L synergistically promote plasma cell differentiation through upregulation of Blimp-1 in human B cells. J Immunol. 2013; 190 (4): 1827-1836.
30. Goldstein H, Kim A. Immunoglobulin secretion and phosphorylation of common proteins are induced by IL-2, IL-4, and IL-6 in the factor responsive human B cell line, SKW6.4. J Immunol. 1993; 151 (12): 6701-6711.
31. Kocemba KA, van Andel H, de Haan-Kramer A, et al. The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis. Leukemia. 2013; 27 (8): 1729-1737.
32. van Boxtel R, Gomez-Puerto C, Mokry M, et al. FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis. Cell Death Differ. 2013; 20 (9): 1219-1229.
33. Rampanelli E, Dessing MC, Claessen N, et al. CD44-deficiency attenuates the immunologic responses to LPS and delays the onset of endotoxic shock-induced renal inflammation and dysfunction. PLoS One. 2013; 8 (12): e84479.
34. Bende RJ, Jochems GJ, Frame TH, et al. Effects of IL-4, IL-5, and IL-6 on growth and immunoglobulin production of Epstein-Barr virusinfected human B cells. Cell Immunol. 1992; 143 (2): 310-323.
35. Gutiérrez NC, Ocio EM, de Las Rivas J, et al. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia. 2007; 21 (3): 541-549.
36. Shaffer AL, Wright G, Yang L, et al. A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol Rev. 2006; 210 (1): 67-85.
37. Kuo TC, Shaffer AL, Haddad J Jr, Choi YS, Staudt LM, Calame K. Repression of BCL-6 is required for the formation of human memory B cells in vitro. J Exp Med. 2007; 204 (4): 819-830.
38. Dogan I, Bertocci B, Vilmont V, et al. Multiple layers of B cell memory with different effector functions. Nat Immunol. 2009; 10 (12): 1292-1299.
39. Pape KA, Taylor JJ, Maul RW, Gearhart PJ, Jenkins MK. Different B cell populations mediate early and late memory during an endogenous immune response. Science. 2011; 331 (6021): 1203-1207.
40. Kometani K, Nakagawa R, Shinnakasu R, et al. Repression of the transcription factor Bach2 contributes to predisposition of IgG1 memory B cells toward plasma cell differentiation. Immunity. 2013; 39 (1): 136-147.
41. Berkowska MA, Schickel JN, Grosserichter- Wagener C, et al. Circulating human CD27-IgA1 memory B cells recognize bacteria with polyreactive Igs. J Immunol. 2015; 195 (4): 1417-1426.
42. Fornek JL, Tygrett LT, Waldschmidt TJ, Poli V, Rickert RC, Kansas GS. Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells. Blood. 2006; 107 (3): 1085-1091.
43. Taylor JJ, Jenkins MK, Pape KA. Heterogeneity in the differentiation and function of memory B cells. Trends Immunol. 2012; 33 (12): 590-597.
44. Berkowska MA, Driessen GJ, Bikos V, et al. Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood. 2011; 118 (8): 2150-2158.
45. Bende RJ, van Maldegem F, Triesscheijn M, Wormhoudt TA, Guijt R, van Noesel CJ. Germinal centers in human lymph nodes contain reactivated memory B cells. J Exp Med. 2007; 204 (11): 2655-2665.
46. Seifert M, Küppers R. Molecular footprints of a germinal center derivation of human IgM1 (IgD1)CD271 B cells and the dynamics of memory B cell generation. J Exp Med. 2009; 206 (12): 2659-2669.
47. Martin SW, Goodnow CC. Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory. Nat Immunol. 2002; 3 (2): 182-188.
48. Horikawa K, Martin SW, Pogue SL, et al. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors. J Exp Med. 2007; 204 (4): 759-769.
49. Engels N, König LM, Heemann C, et al. Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptorintrinsic costimulation to class-switched B cells. Nat Immunol. 2009; 10 (9): 1018-1025.
50. Liu W, Chen E, Zhao XW, et al. The scaffolding protein synapse-associated protein 97 is required for enhanced signaling through isotype-switched IgG memory B cell receptors. Sci Signal. 2012; 5 (235): ra54.
51. Zuccarino-Catania GV, Sadanand S, Weisel FJ, et al. CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype. Nat Immunol. 2014; 15 (7): 631-637.
52. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004; 103 (1): 275-282.
53. Staudt LM, Dave S. The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol. 2005; 87: 163-208.
54. Shaffer AL III, Young RM, Staudt LM. Pathogenesis of human B cell lymphomas. Annu Rev Immunol. 2012; 30 (1): 565-610.
55. Basso K, Dalla-Favera R. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis. Adv Immunol. 2010; 105: 193-210.
56. Vegliante MC, Palomero J, Pérez-Galán P, et al. SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma. Blood. 2013; 121 (12): 2175-2185.